Mediphage Bioceuticals Competitors and Similar CompaniesClear all
Mediphage Bioceuticals's competitors and similar companies include Cell Therapies, Ambrx and Ethris.
 Mediphage Bioceuticals Mediphage Bioceuticals is a genetic medicine company developing a non-viral gene delivery vector platform. |  Cell Therapies Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products. |  Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. |  Ethris Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia. | |
Founding Date | Founding Date 2016 | Founding Date 2003 | Founding Date 2003 | Founding Date 2009 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Toronto, CA HQ | Locations Melbourne, AU HQ | Locations San Diego, US HQ | Locations Planegg, DE HQ |
Employees | Employees 1023% decrease | Employees 733% decrease | Employees 70 | Employees 504% decrease |
Funding | ||||
Total funding raised | Total funding raised $ 4.1m | Total funding raised N/A | Total funding raised $ 347.9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Cell Therapies
HQ
Melbourne, AU
Employees
73↓ 3% decrease
Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products.
View companyAmbrx
HQ
San Diego, US
Employees
70
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
View companyEthris
HQ
Planegg, DE
Employees
50↓ 4% decrease
Ethris is a biopharmaceutical company focused on developing therapies for pulmonary diseases such as primary ciliary dyskinesia.
View company